InvestorX
SEDAR® Issuer number:
00035516
Company name:
Neurogene Inc. (formerly Neoleukin Therapeutics, Inc.)
Document type:
52-109F1 - Certification of annual filings - CFO (E)
Project number:
06107353
Filing date:
03-28-2024